Aktionärsstruktur der Biogen
Portrait der Biogen Aktie
Das Unternehmen Biogen aus USA ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Biogen ist in mehr als 63 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Biogen mit 4,14% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Biogen Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Biogen am höchsten gewichtet ist Insgesamt in 63 ETFs enthalten
Dir gefallen die Informationen zu Biogen?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Biogen?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Biogen?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Biogen?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
322 News & Informationen zur Biogen Aktie
Aktien New York Schluss: Konjunkturoptimismus hält Rekordrally am Laufen
Die Rekordjagd an der Wall Street ist am Donnerstag in eine neue Runde gegangen. Sowohl die wichtigsten Technologiewerte-Indizes als auch der den breiten Markt abbildende S&P 500 legten zu und erreichten im…
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.95%
Nasdaq and S&P 500 scale new peaks; Dow rallies
The Nasdaq and the S&P 500 indexes hit all-time highs on Thursday, with the Dow also jumping, as U.S. President Joe Biden embraced a bipartisan Senate infrastructure deal. After the…
These 2 Key Themes Are Driving the Stock Market to Record Highs
Find out what you need to know about all-time highs for stocks.
Aktien New York: Daten treiben Tech-Indizes und S&P 500 auf Rekordhochs
Positiv aufgenommene US-Konjunkturdaten haben am Donnerstag die Rekordjagd an der Wall Street angefeuert. Sowohl die wichtigsten Technologiewerte-Indizes als auch der den breiten Markt abbildende S&P 500 legten zu und…
Eli Lilly to Seek FDA Approval for Alzheimer’s Drug
The drugmaker said donanemab, which is similar in ways to a recently approved therapy from Biogen, has been designated for an expedited review.
BIIB breakthough Alzheimer drug (GAP UP) : stocks
Biogen Inc granted breakthrough therapy U.S. Food and Drug Administration and has designation to their experimental therapy, lecanemab, for patients …
Why Eli Lilly Stock Is Soaring Today
The company's promising Alzheimer's disease drug won FDA Breakthrough Therapy designation.
+++Börsen-Ticker+++ – SMI klar im Plus – Schliesst knapp unter 12'000 Punkten
Die Schweizer Börse hat am Donnerstag auf breiter Front angezogen.
Nasdaq, S&P 500 scale new peak as weekly jobs recovery gains traction
Read more about Nasdaq, S&P 500 scale new peak as weekly jobs recovery gains traction on Business Standard. Tesla shares boost Nasdaq, S&P 500; Lilly jumps on plans to seek approval for Alzheimer's drug
Eli Lilly Soars as Alzheimer’s Therapy Gets FDA’s Breakthrough Tag By Investing.com
Eli Lilly Soars as Alzheimer’s Therapy Gets FDA’s Breakthrough Tag
PreMarket Prep Recap: The 4 Stocks Dennis Dick Bought Yesterday
On Wednesday’s PreMarket Prep, co-hosts Joel Elconin and Dennis Dick discussed the bullish chart setups in several tech stocks.
…
+++Börsen-Ticker+++ – SMI legt deutlich zu
Die Schweizer Börse hat am Donnerstag auf breiter Front angezogen.
Nasdaq, S&P 500 scale new peak as jobs recovery gains traction
The Nasdaq and the S&P 500 indexes hit all-time highs on Thursday, boosted by shares of Tesla and other top-shelf technology firms as data showing fewer weekly jobless claims bolstered views…
Will Prothena Stock Rebound After A 13% Drop Last Week?
The stock price of Prothena Corporation (NASDAQ: PRTA), a biotechnology company focused on treatment of diseases that involve protein misfolding or cell adhesion, has seen a a large 13% drop over the last five trading days. The decline in PRTA stock came after another pharmaceuticals company…
Eli Lilly's Alzheimer's drug gets FDA Breakthrough Therapy designation
Eli Lilly announced Thursday that it had received the FDA’s Breakthrough Therapy designation for donanemab, an investigational antibody therapy for Alzheimer’s disease.
Aktien New York Ausblick: Höher nach Konjunkturdaten – Nasdaq auf Rekordkurs
Aktien New York Ausblick: Höher nach Konjunkturdaten – Nasdaq auf Rekordkurs | Nachricht | finanzen.net
S&P 500 Poised To Reach New Record Intraday High
The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to move to the upside following the lackluster performance seen in the previous session.
S&P 500 Poised To Reach New Record Intraday High
(RTTNews) – The major U.S. index futures are pointing to a higher open on Thursday, with stocks likely to move to the upside following the lacklus…
Aktien New York Ausblick: Höher nach Konjunkturdaten – Nasdaq auf Rekordkurs
Nach frisch veröffentlichten Wirtschaftsdaten wird der New Yorker Dow Jones Industrial am Donnerstag fester erwartet. Eine Dreiviertelstunde vor dem Börsenstart taxierte der Broker IG den Leitindex mit plus 0,47…
Eli Lilly Alzheimer’s drug gains FDA breakthrough designation
Eli Lill rose after its experimental drug for Alzheimer’s disease gained breakthrough status from US regulators, a designation that will speed its consideration for approval
Eli Lilly Alzheimer’s Drug Gains FDA Breakthrough Designation By Bloomberg
Eli Lilly Alzheimer’s Drug Gains FDA Breakthrough Designation
Intellia Therapeutics Names James Basta, J.D., As Executive Vice President, General Counsel And Corporate Secretary
CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ: NTLA), a leading genome editing company focused on developing curative
Could Cassava Sciences Be a Millionaire-Maker Stock?
Can this biotech underdog develop an Alzheimer's drug investors can count on?
Asian Shares See Muted Gains
(RTTNews) – Asian stocks ended Thursday's session on a firm note, though the upside remained limited after two Fed officials said a period of high…
Asian Shares See Muted Gains
Asian stocks ended Thursday's session on a firm note, though the upside remained limited after two Fed officials said a period of high inflation in the United States could last longer than anticipated.
Biogen: Score A Big Win For Buybacks (NASDAQ:BIIB)
The surprise approval of Aduhelm provided a big financial boost to Biogen. The stock is cheap here as EPS targets reach towards $35 in the near term and $40 over the long term.
Top-Performing Stocks in Historical Low Price-Sales Portfolio as of June
GuruFocus Article or News written by James Li and the topic is about: Stocks with strong year-to-date performance since January
Eisai's drug for Alzheimer's with Biogen gets breakthrough status in U.S.
Japanese company Eisai Co and partner Biogen Inc said on Wednesday the U.S. Food and Drug Administration had granted breakthrough therapy designation to their…
Biogen : Eisai And Biogen Inc. Announce U.S. FDA Grants Breakthrough Therapy Designation For Lecanemab (BAN2401), An Anti-Amyloid Beta Protofibril Antibody For The Treatment Of Alzheimer's Disease
TOKYO and CAMBRIDGE, Mass., June 23, 2021 /PRNewswire/ — Eisai Co., Ltd. and Biogen Inc. today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy… | June 23, 2021
Biogen's drug for Alzheimer's with Eisai gets breakthrough status in U.S
Biogen Inc and Japanese partner Eisai Co said on Wednesday the U.S. Food and Drug Administration had granted breakthrough therapy designation to their…
Ionis Pharmaceuticals Stock Looks Attractive At $37
We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is undervalued at current levels of under $37. IONS stock is down 11% from the levels of around $42 it was at on March 23, 2020…
Biogen : and Eisai Update for the Alzheimer's Disease Community
CAMBRIDGE, Mass. and WOODCLIFF LAKE, N.J., June 23, 2021 – Biogen and Eisai Inc., U.S. subsidiary of Eisai Co., Ltd. today issued the following statement:
On… | June 23, 2021
The 10 Most Upgraded Stocks By Wall Street Analysts In May 2021
Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Oracle Corporation, Adobe Systems Incorporated, Costco Wholesale Corp, Intuit Inc. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com
4 Trending Health Care Stocks To Watch Right Now
Could these health care stocks maintain their growth momentum?
FDA documents show struggle over approval of new Alzheimer's drug from Biogen By Reuters
FDA documents show struggle over approval of new Alzheimer's drug from Biogen
FDA approved Biogen Alzheimer’s drug despite some objections by staff
The U.S. Food and Drug Administration approved the first new Alzheimer’s drug in decades over the objection of agency statisticians who said there was…
ANIKA THERAPEUTICS : 2017 OMNIBUS INCENTIVE PLAN (Form 8-K)
ANIKA THERAPEUTICS, INC.
2017 OMNIBUS INCENTIVE PLAN
Anika Therapeutics, Inc. sets forth herein the terms of its 2017 Omnibus Incentive Plan.
… | June 22, 2021
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.76% By Investing.com
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.76%
Is Align Technology, Inc. (ALGN) Going to Burn These Hedge Funds?
At Insider Monkey, we pore over the filings of nearly 866 top investment firms every quarter, a process we have now completed for the latest reporting…